Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes

Neurology

Volumn 47, Issue 5, 1996, Pages 1317-1320

  Kornberg, Andrew J ^a   Pestronk, Alan ^a,c   Blume, Gregory M ^a   Lopate, Glenn ^a   Yue, Jin ^a   Hahn, Angelika ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Box 8111 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; OPHTHALMOPLEGIA; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME;

EID: 0029905231     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.5.1317     Document Type: Article

References (16)

1. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high titer IgG anti-GM1 antibodies. Ann Neurol 1994; 35:234-237.
2. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
3. Hopper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-1136.
4. Q1b antibody in Fisher's syndrome. Neurology 1993;43:414-417.
5. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
6. 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
7. Willison HJ, Kennedy PGE. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol 1993;46:105-112.
8. Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454-455.
9. Ledeen R. Gangliosides of the neuron. Trends Neurosci 1985; 8:169-174.
10. Yoshino H, Maeda Y, King M, et al. Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of humans. Neurology 1993;43:408-411.
11. Ropper AH, Shahani B. Proposed mechanism of ataxia in Fisher's syndrome. Arch Neurol 1983;40:537-538.
12. Sauron B, Bouche P, Cathala HP, Chain F, Castaigne P. Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology 1984;34:953-956.
13. Petty RKH, Duncan R, Jamal GA, Hadley D, Kennedy PGE. Brainstem encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1993;56:201-203.
14. Yuki N, Sato S, Tsuji S, Hozumi I, Miyatake T. An immunologic abnormality common to Bickerstaff s brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993;118: 83-87.
15. Yaqub BA, al-Deeb SM, Daif AK, et al. Bickerstaff brainstem encephalitis. A grave non-demyelinating disease with benign prognosis. J Neurol Sci 1990;96:29-40.
16. Kotani M, Kawashima I, Ozawa H, Terashima T, Tai T. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 1993;3:137-146.